- Trials with a EudraCT protocol (957)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
957 result(s) found for: Hepatitis C virus.
Displaying page 1 of 48.
EudraCT Number: 2006-002483-26 | Sponsor Protocol Number: 1998/2005 | Start Date*: 2005-12-01 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Tailoring antiviral therapy of chronic hepatitis C to the single patient standard therapy versus treatment guided by a physic-mathematical model of the dynamics of Hepatitis C Virus infection. | |||||||||||||
Medical condition: Chronic Hepatitis C with or without cirrhosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006588-21 | Sponsor Protocol Number: HLS02/2006 | Start Date*: 2007-05-10 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: Fluvastatin as adjuvant therapy to alfa-interferon and ribavirin in the treatment of chronic hepatitis C in patients with HIV-1 coinfection | |||||||||||||
Medical condition: Chronic hepatitis C in HIV/HCV coinfection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000279-40 | Sponsor Protocol Number: SF3PEG-RIBA | Start Date*: 2007-02-15 | |||||||||||
Sponsor Name:A.S.L. 2 | |||||||||||||
Full Title: Randomised phase 3B study on comparison of 2 treatment schedules with peginterferon alpha 2b and ribavirin short term versus standard term schedules in patients with chronic hepatitis C, genotype... | |||||||||||||
Medical condition: Patients with chronic hepatitis C with genotype 2 or 3 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004852-38 | Sponsor Protocol Number: MV 17149 - HELPS | Start Date*: 2005-04-06 | |||||||||||
Sponsor Name:ROCHE | |||||||||||||
Full Title: A randomized, open label, multicenter, parallel group study evaluating the efficacy and safety of 135 mcg and 90 mcg of Pegasys given as monotherapy to patients with chronic hepatitis C and end-sta... | |||||||||||||
Medical condition: chronic hepatitis C CHC virus infection in patients with end-stage renal disease ESRD undergoing hemodialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001927-39 | Sponsor Protocol Number: ST1472-DM-03-007 | Start Date*: 2005-01-20 | |||||||||||
Sponsor Name:SIGMA-TAU | |||||||||||||
Full Title: A PHASE II, MULTICENTER, UNCONTROLLED, OPEN STUDY IN PATIENTS WITH CHRONIC HEPATITIS C WHO ARE INTOLERANT TO INTERFERONS THERAPY TO EVALUATE THE SAFETY AND EFFICACY OF A TREATMENT WITH THYMOSIN ALP... | |||||||||||||
Medical condition: TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C WHO ARE INTOLERANT TO INTERFERONS THERAPY | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003853-29 | Sponsor Protocol Number: METVIRAL | Start Date*: 2005-12-09 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: A randomized, controlled, multicenter clinical trial comparing the efficacy of Peginterferon alfa-2a and ribavirin and metformin versus Peginterferon alfa-2a and ribavirin for the treatment of naïv... | |||||||||||||
Medical condition: CHRONIC ACTIVE HEPATITIS C ASSOCIATED WITH INSULIN RESISTANCE | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004111-37 | Sponsor Protocol Number: BHC-ABT-001 | Start Date*: 2014-10-22 | |||||||||||
Sponsor Name:BUDAI HEPATOLÓGIAI CENTRUM | |||||||||||||
Full Title: Individual Patient Access to AbbVie ABT-450/rítonavir/ABT-267 and ABT 333 Coadministered witb Ribavirín (RBV) in Patient with Genotype 1 Hepatitis C Vírus Infection witb Cirrhosis | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006221-27 | Sponsor Protocol Number: 146/2007/U/Sper | Start Date*: 2008-04-01 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Immunosuppression without calcineurin inhibitors and with the use of everolimus (Certican) in HCV-infected liver transplant patients | |||||||||||||
Medical condition: HCV cirrhosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018361-33 | Sponsor Protocol Number: HCV689-201 | Start Date*: 2010-09-10 | ||||||||||||||||||||||||||
Sponsor Name:Arrow Therapeutics Ltd. (a member of the AstraZeneca group of companies) | ||||||||||||||||||||||||||||
Full Title: A Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AZD7295 in Combination with Pegylated Interferon alpha-2a and Ribavirin in P... | ||||||||||||||||||||||||||||
Medical condition: Chronic hepatitis C virus (genotype 1b) infection | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: SK (Completed) HU (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004394-90 | Sponsor Protocol Number: IM1 | Start Date*: 2012-01-05 | ||||||||||||||||
Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Gastroenterologie und Hepatologie | ||||||||||||||||||
Full Title: Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - IM1 | ||||||||||||||||||
Medical condition: Patients with CHC and liver cirrhosis who are not applicable to standard therapy due to the presence of a contraindication. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-004212-64 | Sponsor Protocol Number: IMC-I109V-101 | Start Date*: 2020-08-12 | ||||||||||||||||
Sponsor Name:Immunocore Ltd | ||||||||||||||||||
Full Title: An Open-label Study Evaluating the Safety, Antiviral Activity, and Pharmacokinetics of IMC-I109V in HLA-A*02:01 Positive Patients with Chronic HBV who are Non-Cirrhotic, Hepatitis B e Antigen-nega... | ||||||||||||||||||
Medical condition: chronic hepatitis B virus (HBV) infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) GB (GB - no longer in EU/EEA) PL (Ongoing) RO (Completed) DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002069-77 | Sponsor Protocol Number: RG101-05 | Start Date*: 2016-12-01 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Regulus Therapeutics Inc. | ||||||||||||||||||||||||||||||||||||||
Full Title: An Observational Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Have Previously Received RG-101 | ||||||||||||||||||||||||||||||||||||||
Medical condition: Hepatitis C Patients | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: GR (Completed) HU (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001942-16 | Sponsor Protocol Number: GS-US-334-0133 | Start Date*: 2012-08-10 | ||||||||||||||||
Sponsor Name:Gilead Sciences Inc. | ||||||||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Investigate the Efficacy and Safety of GS-7977 + Ribavirin for 12 Weeks in Treatment-Naïve and Treatment-Experienced Su... | ||||||||||||||||||
Medical condition: Chronic Genotype 2 or 3 HCV Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: EE (Completed) AT (Completed) NL (Completed) DE (Completed) GB (Completed) SE (Completed) ES (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003446-27 | Sponsor Protocol Number: TMC435HPC3021 | Start Date*: 2015-01-02 | |||||||||||
Sponsor Name:Janssen R&D Ireland | |||||||||||||
Full Title: A Phase 3, Multicenter, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of a 12-Week Regimen of Simeprevir in Combination with Sofosbuvir in Treatment-Naïve or -Experienced Subj... | |||||||||||||
Medical condition: Hepatitis C-Infection genotype 4 Patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000328-42 | Sponsor Protocol Number: CP-104 | Start Date*: 2007-08-03 | |||||||||||
Sponsor Name:Arrow Therapeutics Ltd | |||||||||||||
Full Title: A clinical pharmacology study to determine the pharmacokinetic , safety and tolerability profile and antiviral activity of multiple oral doses of A-831 in otherwise healthy male Hepatitis C carrie... | |||||||||||||
Medical condition: Male Hepatitis C carriers with compensated liver disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011464-11 | Sponsor Protocol Number: VX08-950-112 | Start Date*: 2009-10-20 | |||||||||||
Sponsor Name:Vertex Pharamceuticals, Inc. | |||||||||||||
Full Title: EXTEND: A 3-Year, Virology, Follow-up Study in Subjects Previously Treated With Telaprevir in Select Clinical Studies | |||||||||||||
Medical condition: Hepatitis C virus infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003879-18 | Sponsor Protocol Number: SOF-VEL/PED/2020 | Start Date*: 2021-04-21 | |||||||||||
Sponsor Name:Medical University of Warsaw | |||||||||||||
Full Title: Treatment of chronic hepatitis C in children aged 6 – 18 years using a pangenotypic direct-acting antiviral (sofosbuvir/velpatasvir) | |||||||||||||
Medical condition: Chronic hepatitis C | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021113-23 | Sponsor Protocol Number: TMC435HPC3007 | Start Date*: 2010-12-23 | |||||||||||
Sponsor Name:Tibotec Pharmaceuticals | |||||||||||||
Full Title: ""Estudio en fase III, aleatorizado, doble ciego y controlado con placebo para investigar la eficacia, la seguridad y la tolerabilidad de TMC435 frente a placebo como parte de una pauta con peginte... | |||||||||||||
Medical condition: Hepatitis C Virus (HCV) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DE (Completed) BE (Completed) GB (Completed) AT (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023669-23 | Sponsor Protocol Number: VX-950HEP3002 | Start Date*: 2011-04-06 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: Multicenter, Open-Label, Early Access Program of Telaprevir in Combination With Peginterferon Alfa and Ribavirin in Genotype 1 Chronic Hepatitis C Subjects With Severe Fibrosis and Compensated Cirr... | |||||||||||||
Medical condition: Chronic hepatitis C infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) IT (Completed) CZ (Completed) GR (Completed) ES (Completed) HU (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021337-31 | Sponsor Protocol Number: TMC435-TiDP16-C212 | Start Date*: 2011-11-03 | |||||||||||
Sponsor Name:Janssen R&D Ireland | |||||||||||||
Full Title: A Phase III open-label study to evaluate the safety, tolerability and efficacy of TMC435 plus PegIFNα-2a (Pegasys) and ribavirin (Copegus) triple therapy in chronic hepatitis C genotype-1 infected ... | |||||||||||||
Medical condition: Hepatitis C and co-infected with HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) PT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
